Preloaded gas inflation device for balloon catheter

Information

  • Patent Grant
  • 6471671
  • Patent Number
    6,471,671
  • Date Filed
    Wednesday, August 23, 2000
    24 years ago
  • Date Issued
    Tuesday, October 29, 2002
    22 years ago
Abstract
An inflation device such as a syringe is preloaded with gas (other than air) for inflation of balloon catheters. The syringe is lined with, or is packaged within, a low gas-permeability membrane to keep the stored gas from becoming contaminated with air. The physician using the syringe is able to determine whether air has infiltrated the syringe and contaminated the gas stored in the syringe.
Description




FIELD OF THE INVENTION




The present invention generally relates to closed volume inflation devices. In particular, the present invention relates to inflation devices such as syringes used to inflate and deflate balloon catheters.




BACKGROUND OF THE INVENTION




Balloon catheters are sometimes inflated with gas, rather than liquid, because the balloon can be inflated and deflated more quickly than a comparable volume of saline or other liquid inflation media. Gas inflation has proved particularly useful in inflation of balloon centering catheters used in radiation therapy, which relies on a centering balloon to prevent the radiation source from being too close to one side of the target vessel. The use of gas rather than liquid decreases the amount of attenuation of radiation between the radiation source and the vessel wall.




While gas filled balloons are advantageous in some situations, the prior art process of preparing an inflation device for gas inflation is much more complicated than that for liquid inflation. Although air would be relatively easy to load into an inflation device, air is not a suitable inflation medium, because air does not rapidly dissolve in blood. In the event that the balloon bursts or leaks, bubbles could be formed in the arterial blood, impeding blood flow. In addition, a chief component of air, nitrogen, is not desirable for balloon inflation because nitrogen gas has thrombogenic properties which may present clinical risks in the event that the balloon bursts. Accordingly, it is desirable to use a gas other than air and to prevent air contamination of the gas used. A preferable gas used for balloon inflation is carbon dioxide.




Many medical facilities have built-in plumbing systems that provide gases such as carbon dioxide. Alternatively, a pressurized gas canister of carbon dioxide may be used. In either case, the pressurized source of carbon dioxide must be connected to a reduction valve to fill the inflation device with gas. The reduction valve lowers the pressure of the gas to a pressure suitable for the syringe. The reduction valve may utilize several stopcocks that must be opened for the gas to flow. For example, a first stopcock may be located at the reduction valve, a second stopcock may be located at the catheter connection point, and a third stopcock may be located at the syringe. Such systems are physically cumbersome and unwieldy, and require considerable preparation time by skilled medical personnel. Accordingly, a desirable feature in an inflation device would be an inflation syringe preloaded with a specified gas which the physician could conveniently use without extensive preparation and equipment.




Unfortunately, however, the storage of gas in a syringe mechanism presents several difficulties. Most plastics used in syringe manufacture are gas-permeable, at least to some extent. In addition, most stopcocks and syringe plungers, even when manufactured to precise specifications, are subject to leakage over extended periods of storage. Finally, packaging materials used to maintain sterility are usually gas permeable to facilitate ETO sterilization. These factors contribute to loss of the stored gas and/or contamination of the stored gas by air.




SUMMARY OF THE INVENTION




The preloaded inflation device of the present invention is suitable for inflating and deflating a wide variety of balloon catheters such as a centering balloon catheter or an angioplasty balloon catheter. In addition, although described with specific reference to a syringe type inflation device for purposes of illustration, other closed volume inflation devices are within the scope of the present invention.




The present invention provides several embodiments of an inflation device preloaded with an inflation gas (other than air). As used herein, the term inflation gas refers to any gas, other than air, that is suitable for balloon catheter inflation such as carbon dioxide gas. The present invention also provides means for preventing air contamination of the inflation gas contained in the inflation device. In addition, the present invention enables the user to positively confirm that no air contamination of the inflation gas stored in the inflation device has occurred.




The present invention generally provides for an inflation device which is preloaded with an inflation gas, such as carbon dioxide gas, for balloon inflation. The inflation device is preferably preloaded by the manufacturer and/or packager of the inflation device. The inflation device generally has a body with a chamber preloaded with the inflation gas, and includes some means for preventing air contamination of the inflation gas. The means for preventing air contamination may vary according to the particular embodiment of the invention.




In a first embodiment of the present invention, a syringe is preloaded with a gas suitable for balloon inflation, such as carbon dioxide, and then placed in a container such as a pouch or envelope that has low gas-permeability. The container is filled with the same gas as that loaded into the syringe, at approximately the same pressure, after which the container is sealed. Because the container has low gas-permeability, air is not able to enter the container, or the syringe. Although the gas stored in the syringe may exchange with that in the container, there is no contamination since the gases are similar. After the container is sealed, the entire syringe and package may be sterilized with a non-gas based sterilization process, such as gamma or e-beam radiation, in accordance with existing techniques.




In another embodiment of the present invention, the syringe may contain within its main body a capsule of gas, the capsule being made of a gas-impermeable membrane. When the syringe is ready for use, the capsule may be broken or otherwise opened by piercing or cutting the membrane. For example, the capsule may be broken manually with a sterile pin. Alternatively, the syringe may contain a small pin or other sharp object pointing generally towards the proximal end of the syringe which punctures the gas capsule when the gas capsule is pressed forward by compression of the syringe plunger. In a preferred embodiment, the capsule is formed in a manner which does not interfere with the compression of the syringe plunger (i.e., the plunger will not get entrapped on the compressed capsule).




In a further embodiment of the present invention, the inflation gas is stored in a syringe that is sealed by a membrane, preferably located at the distal opening of the syringe. Although the gas contained within the syringe may pass in minute quantities through the plunger seal, the distal sealing membrane, or the syringe body itself, particularly if the syringe tubular body is constructed of a plastic material which is gas-permeable, air contamination is detectable by having a-nitrogen-sensing strip packaged within the syringe. When the syringe is to be used, the membrane at the distal opening of the catheter may be cut, punctured, or otherwise opened. With this embodiment, a small strip is treated or coated with a chemical that changes appearance (e.g., color) in the presence of an unacceptable amount of nitrogen gas. A nitrogen sensing strip may also be disposed in the pouch containing the syringe in the first embodiment. At the time of use, the color of the strip may be checked to ensure that an unacceptable amount of air has not infiltrated the syringe.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a plan view of an inflation device and package in accordance with a first embodiment of the present invention, showing a syringe preloaded with an inflation gas and packaged in a gas-impermeable pouch;





FIG. 2

is a cross-sectional view of an inflation device (package not shown) in accordance with an alternative embodiment of the present invention, showing a syringe containing a gas-impermeable capsule preloaded with an inflation gas;





FIG. 3

is a cross-sectional view of an alternate embodiment of the inflation device illustrated in

FIG. 2

, wherein the capsule is articulated and further including a puncturing device for puncturing the capsule; and





FIGS. 4A and 4B

are cross-sectional and plan views respectively of an alternative puncturing device for use with embodiments of FIGS.


2


and


3


.











DETAILED DESCRIPTION OF THE PRESENT INVENTION




The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.




As mentioned previously, each preloaded inflation device embodiment of the present invention is suitable for inflating and deflating a wide variety of balloon catheters such as centering balloon catheters and angioplasty balloon catheters. In the field of intravascular ionizing radiation therapy, gas inflation of centering balloon catheters is particularly useful because gas inflation media, as compared to liquid inflation media, decreases the amount of attenuation of radiation between the radiation source and the vessel wall. Accordingly, a system comprising an inflation device as described herein in combination with a balloon catheter, such as a centering balloon catheter or an angioplasty balloon catheter, is within the scope of the present invention. An example of a suitable centering balloon catheter for use in intravascular ionizing radiation therapy is described in European Patent No. 688 580 to Verin et al., which is hereby incorporated in its entirety by reference.




Also as mentioned previously, although described with specific reference to a syringe type inflation device for purposes of illustration, other closed volume inflation devices are within the scope of the present invention. For example, all types of piston and barrel inflation devices are contemplated by the present invention.




The present invention provides several embodiments of an inflation device preloaded with an inflation gas (other than air). As used herein, the term inflation gas refers to any gas, other than air, that is suitable for balloon catheter inflation. Carbon dioxide gas is the preferred choice, but other non-thrombogenic gases or mixtures with high solubility in blood may be employed.




With reference to

FIG. 1

, a first embodiment of the present invention utilizes a pouch


103


having low gas permeability to prevent air from infiltrating the inflation device


102


. The end-user (physician, clinician, or lab tech) receives the packaged inflation device shown generally at


101


, including a syringe


102


disposed in the low gas permeability pouch


103


. The low gas-permeability pouch may be formed of a wide variety of low gas-permeability materials and composites such as metal foils, metal foil/polymer composites, polyethylene terephthalate (PET), PET/aluminum or polyvinyl fluoride (PVF). Instead of a pouch, a hermetically sealed metal container (such as the can in which tennis balls are sold) could be used. At the manufacturing/packaging stage, the syringe


102


may be filled with the inflation gas after which the stopcock


108


is closed. Similarly, the pouch


103


may be filled with the inflation gas after which the pouch is sealed. Conventional techniques may be used to seal the inflation device


102


in the pouch


103


, which remains sealed until it is opened by the physician at the time the inflation device


102


is to be used.




The syringe


102


, consisting of plunger


104


, plunger seal


105


, tubular body


106


, and reduction tube


107


, may be coupled to a balloon catheter (not shown) by a standard stopcock


108


utilizing standard catheter fittings. Because the pouch


103


is formed of low gas-permeability material and since the pouch


103


is filled with the same gas as contained in the syringe


102


, the components of the syringe


102


may formed of conventional materials using conventional techniques. However, to further reduce the tendency of the inflation gas to become contaminated with air or other undesirable gases, the components


104


,


105


,


106


and


107


of the syringe


102


, including the stopcock


108


, may be formed in part or in whole of materials having low gas-permeability.




The stopcock


108


may be connected to a catheter at port


109


, and may be further coupled to an evacuation or aspiration syringe at port


110


. Alternately, the reduction tube


107


may utilize a standard catheter fitting and be connected directly to the desired catheter. Those skilled in the art will recognize that many suitable means may be used to connect the inflation device


102


to any desired catheter without departing from the present invention.




Preferably, the volume of inflation gas within the syringe


102


is equal to or greater than the volume required to inflate the desired balloon catheter. For example, for PTCA (percutaneous translumenal coronary angioplasty) balloon catheters and other coronary balloon catheters (e.g., centering catheters), as much as 3cc to 20cc is required due to the high compressability of gas. Note that the inflation gas volume may be adjusted for differences in pressure and temperature between the manufacturing/packaging stage and the end use stage. The syringe


102


may have graduated indications of volume that can be referred to by a physician to determine an approximate volume of inflation gas contained in the syringe


102


.




The embodiment illustrated in

FIG. 1

may further include a nitrogen-sensing indicator strip


111


located inside the pouch


103


as shown and/or in the body


106


of the syringe


102


. The nitrogen-sensing indicator strip


111


visually indicates (e.g., by color change) the presence of nitrogen gas. The nitrogen-sensing indicator strip


111


comprises a small strip of substrate which is treated or coated with a chemical reagent that changes appearance (e.g., color) in the presence of nitrogen gas. Alternatively, a small strip of calcium metal, for example, that changes appearance in the presence of nitrogen may be used, as detailed in U.S. Pat. No. 4,848,138 to Marshall, which is hereby incorporated by reference in its entirety.




If the nitrogen indicator strip


111


is located inside the pouch


103


, it may be viewed through transparent pouch


103


prior to opening. If the nitrogen indicator strip


111


is located inside the syringe body


106


, it may be viewed through transparent or translucent syringe tubular body


106


. Thus, the nitrogen-sensing indicator strip


111


indicates whether the inside of the pouch


103


and/or the inside of the syringe has been infiltrated by air during shipment or storage. In this manner, the nitrogen-sensing strip


111


may be used to ensure and confirm that the inflation gas has not been contaminated.




With reference to

FIG. 2

, a cross-sectional view of an inflation device


201


(package not shown) in accordance with an alternative embodiment of the present invention is shown. Except as described herein, the inflation device


201


illustrated in

FIG. 2

is the same as inflation device


102


described with reference to FIG.


1


. The inflation device illustrated in

FIG. 2

is shown as a syringe


201


which includes a plunger


204


, a plunger seal


205


, a tubular body


206


, and a reduction tube


207


which is connected to a standard stopcock


208


with catheter connection


209


and evacuation syringe connection


210


. The syringe


202


further contains within the tubular body


206


a sealed gas capsule


211


, which is constructed from a low gas-permeability membrane. Suitable materials for the low gas permeability membrane forming the capsule


211


include the materials described previously with reference to pouch


103


. The capsule


211


is filled during the manufacturing/packaging stage with the inflation gas, and may be placed in the body


206


of the syringe


201


at the same stage or just prior to use.




Although a low gas-permeability pouch


103


filled with an inflation gas as described with reference to

FIG. 1

is not necessary for packaging inflation device


201


, such a pouch


103


may be used with this embodiment to further ensure that no contamination of the inflation gas stored in the capsule


211


takes place. In addition, a nitrogen sensing strip


213


similar to strip


111


may be placed in the capsule


211


in order to confirm that the inflation gas stored in the capsule


211


has not been contaminated by air.




Prior to use, the low gas-permeability membrane forming the capsule


211


may be punctured or otherwise opened with a sterile needle inserted through the reduction tube


207


(with the stopcock


208


temporarily taken off). Preferably, in order to facilitate easy puncturing, the capsule


211


is sufficiently filled with inflation gas such that the membrane expands to contact the inner wall of the body


206


and plunger seal


205


. Alternatively, rather than using a puncturing mechanism, the capsule


211


may have a thinner walled membrane


212


at the part of the capsule


211


adjacent the reduction tube


207


of the syringe


201


. In this manner, when the syringe plunger


204


is depressed, the capsule


211


will break in the area


212


under the increased pressure inside the capsule.




Puncturing the membrane of the capsule


211


may be done after confirming that no air has infiltrated the capsule


211


by checking the nitrogen indicator strip


213


through the transparent or translucent wall of tubular body


206


.




Aside from the thin-walled area


212


, the membrane forming the capsule


211


may have a relatively uniform profile and wall thickness. Alternatively, an articulated capsule


302


may be used as illustrated in FIG.


3


. Except as described herein, the inflation device


301


illustrated in

FIG. 3

is the same as inflation device


201


described with reference to FIG.


2


. The membrane forming the articulated capsule


302


includes a plurality of small reversing folds resembling those of a bellows or accordion. As the plunger


303


is compressed to expel inflation gas from the capsule


302


, the collapsing capsule


302


does not interfere with the movement of the plunger


303


in the tubular body


306


. In other words, the plunger


303


and the plunger seal


304


will not catch or jam on the capsule membrane


302


as it is compressed.




Also shown in

FIG. 3

, the present invention may have a self-puncturing means


305


, fitted within or otherwise attached to the inside of reduction tube


307


. Of course, the self-puncturing means


305


may also be used with syringe


201


to puncture the membrane of capsule


211


. In addition, those skilled in the art will recognize that many suitable alternative puncturing mechanisms may be employed in addition to the mechanisms disclosed herein. The self-puncturing means


305


perforates or punctures the membrane of the capsule


302


when pressure is exerted on the capsule


302


by plunger


303


. The pressure of the inflation gas in the capsule


302


will provide greater resistance to the syringe plunger


303


initially, until the capsule


302


is forced at its distal end


308


into the puncturing pin


305


. The self-puncturing means


305


increases the convenience of the syringe, because no additional puncturing actions are required other than merely depressing the syringe plunger


303


.




As shown in

FIG. 3

, the puncturing pin may be embedded in the syringe reduction tube


307


wall. Alternatively, the puncturing pin


305


may simply be adhesively connected to the inside of the reduction tube


307


. Embedding the pin


305


may be accomplished by insert molding the pin


305


in the wall of the reduction tube


307


. Alternately, the pin


305


may be forced through the wall of the reduction tube


307


, with or without a pilot hole, and with or without the use of adhesive, to extend through the wall and into the lumen of the reduction tube


307


.




An alternative puncturing member


813


is illustrated in

FIGS. 4A and 4B

. The self-puncturing member


809


may be used with syringe


201


to puncture the membrane of capsule


211


or with syringe


301


to puncture the membrane of capsule


302


. The puncturing member


809


is formed from a tubular metallic member


810


. Puncturing member


809


is formed in tubular metallic member


810


by making two cuts


811


and


812


that meet at the point of puncturing member


809


. Puncturing member


809


is then bent inward toward the middle of tubular metallic member


810


. As depicted in

FIG. 8A

, after being bent in, the puncturing member


813


intrudes into the lumen of the tubular metallic member. This tubular metallic member


810


may be press fit into the syringe reduction tube


207


or


307


. When placed in the reduction tube


207


or


307


, the puncturing member


809


is in a position to puncture the gas-impermeable capsule


211


or


302


when the membrane intrudes into the lumen of tubular metallic member


810


. Furthermore, it is contemplated that puncturing may take place automatically during the process of attaching the catheter to the syringe.




From the foregoing, it should be apparent to those skilled in the art that the present invention generally provides for various embodiments of inflation devices


102


,


201


,


301


,


402


which are preloaded with an inflation gas, such as carbon dioxide gas, for balloon inflation. The inflation devices are preferably preloaded by the manufacturer and/or packager. Each inflation device generally has a body with a chamber preloaded with the inflation gas, and each device includes some means for preventing air contamination of the inflation gas. The means for preventing air contamination may vary according to the particular embodiment as described above.




Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.



Claims
  • 1. An inflation device, comprising:a body having a chamber therein; an inflation gas other than air contained in the chamber; and means for preventing air contamination of the inflation gas.
  • 2. An inflation device as in claim 1, wherein the inflation gas comprises carbon dioxide.
  • 3. An inflation device as in claim 1, wherein the body comprises a syringe.
  • 4. An inflation device as in claim 1, further comprising a nitrogen detection strip disposed in the chamber.
  • 5. An inflation device as in claim 1, wherein the contamination preventing means comprises a gas-impermeable sealed container enclosing the body and containing a gas other than air.
  • 6. An inflation device as in claim 5, wherein the gas in the container comprises the inflation gas.
  • 7. An inflation device as in claim 1, wherein the contamination preventing means comprises a gas-impermeable sealed capsule disposed in the chamber and containing the inflation gas.
  • 8. An inflation device as in claim 7, wherein the sealed capsule is articulated.
  • 9. An inflation device as in claim 7, further comprising a puncturing member disposed adjacent the capsule such that the capsule is punctured by the puncturing member upon compression of the capsule.
  • 10. An inflation device as in claim 9, wherein the puncturing member comprises a tubular member having a sharp protrusion.
  • 11. A method of filling a chamber in an inflation device with a gas, comprising the steps of:filling the inflation device chamber with an inflation gas other than air at a pressure greater than one atmosphere; and sealing the distal opening of the inflation device with a puncturable membrane which prevents the inflation gas from escaping.
  • 12. A packaged inflation device for inflating a balloon catheter, comprising:a pressure source comprising: a chamber; a plunger disposed in the chamber; an inflation gas other than air stored in said chamber; and a gas-sealed container, wherein the pressure source is disposed within said container, the container being filled with the same gas as the chamber.
  • 13. An inflation device for inflating a balloon catheter, comprising:a chamber; a low gas-permability membrane disposed in the chamber and being formed into a hollow capsule, the capsule containing an inflation gas, the membrane being sealed so as to isolate the inflation gas from the atmospheric gases outside the capsule.
  • 14. A syringe for holding and delivering gas inflation media for inflation of balloon catheters, comprising:a tubular body member having an inner lumen, a tube wall, and distal and proximal ends, said tubular body being filled with a gas at a pressure greater than one atmosphere; a reduction tube having an inner lumen, a tube wall, and distal and proximal ends, joined to the distal end of the tubular body member, the reduction tube inner lumen being narrower than the tubular body inner lumen, and being in fluid communication with the tubular body member; a fitting disposed at the distal end of the reduction tube; a plunger member disposed within the tubular body; and a distal membrane disposed at the distal end of the chamber, the distal membrane isolating the inflation gas from atmospheric gases outside the syringe.
US Referenced Citations (66)
Number Name Date Kind
3688765 Gasaway Sep 1972 A
3939834 McMahon Feb 1976 A
4234026 Bayham Nov 1980 A
4573977 Crawford Mar 1986 A
4713060 Riuli Dec 1987 A
4793351 Landman et al. Dec 1988 A
4795431 Walling Jan 1989 A
4848138 Marshall Jul 1989 A
4865587 Walling Sep 1989 A
4878903 Mueller Nov 1989 A
4944726 Hilal et al. Jul 1990 A
4968302 Schluter et al. Nov 1990 A
5168757 Rabenau et al. Dec 1992 A
5224933 Bromander Jul 1993 A
5318522 D'Antonio Jun 1994 A
5855546 Hastings et al. Jan 1999 A
6090035 Campbell et al. Jul 2000 A
6099455 Columbo et al. Aug 2000 A
6102931 Thornton Aug 2000 A
6106454 Berg et al. Aug 2000 A
6110097 Hastings et al. Aug 2000 A
6117065 Hastings et al. Sep 2000 A
6142926 Schneiderman Nov 2000 A
6149574 Trauthen et al. Nov 2000 A
6149575 Leonhardt Nov 2000 A
6152869 Park et al. Nov 2000 A
6162165 Apple et al. Dec 2000 A
6179768 Loffler et al. Jan 2001 B1
6200256 Weinberger Mar 2001 B1
6200257 Winkler Mar 2001 B1
6200307 Kasinkas et al. Mar 2001 B1
6203485 Urick Mar 2001 B1
6213976 Trerotola Apr 2001 B1
6217503 Weinberger et al. Apr 2001 B1
6224535 Chiu et al. May 2001 B1
6224536 Pike May 2001 B1
6231494 Verin et al. May 2001 B1
6231495 Denk May 2001 B1
6231719 Garvey et al. May 2001 B1
6234951 Hastings May 2001 B1
6234952 Lipric May 2001 B1
6238332 Kanesaka May 2001 B1
6241719 Wallace et al. Jun 2001 B1
6248057 Mavity et al. Jun 2001 B1
6251059 Apple et al. Jun 2001 B1
6254552 Lewis et al. Jul 2001 B1
6258019 Verin et al. Jul 2001 B1
6261219 Meloul et al. Jul 2001 B1
6264579 Odai et al. Jul 2001 B1
6264595 Delfino et al. Jul 2001 B1
6264596 Weadock Jul 2001 B1
6264598 Armini Jul 2001 B1
6267717 Stoll et al. Jul 2001 B1
6267775 Clerc et al. Jul 2001 B1
6283910 Bradshaw et al. Sep 2001 B1
6283911 Keren Sep 2001 B1
6287249 Tam et al. Sep 2001 B1
6296603 Turnlund et al. Oct 2001 B1
6302839 Chernomorsky et al. Oct 2001 B1
6306073 Weinberger Oct 2001 B1
6306074 Waksman et al. Oct 2001 B1
6309339 Ciezki et al. Oct 2001 B1
6293899 Sioshansi et al. Nov 2001 B1
6312374 von Hoffmann Nov 2001 B1
6319190 Schmidt et al. Nov 2001 B1
6322490 Stack et al. Nov 2001 B1
Foreign Referenced Citations (24)
Number Date Country
44 23 261 Jan 1996 DE
197 24 223 Dec 1998 DE
0 351 758 Jan 1990 EP
2000024001 Jan 2000 JP
WO 9845191 Oct 1998 WO
WO 0032271 Jun 2000 WO
WO 0045627 Aug 2000 WO
WO 0056249 Sep 2000 WO
WO 0069503 Nov 2000 WO
WO 0074778 Dec 2000 WO
WO 0076557 Dec 2000 WO
WO 0114011 Mar 2001 WO
WO 0114617 Mar 2001 WO
WO 0121106 Mar 2001 WO
WO 0121245 Mar 2001 WO
WO 0121248 Mar 2001 WO
WO 0126734 Apr 2001 WO
WO 0154764 Aug 2001 WO
WO 0160443 Aug 2001 WO
WO 0162331 Aug 2001 WO
WO 0164123 Sep 2001 WO
WO 0166188 Sep 2001 WO
WO 0185255 Nov 2001 WO
WO 0187400 Nov 2001 WO